P

Pandion Therapeutics

64 employees

Pandion Therapeutics develops innovative modular proteins, antibodies, and bispecifics for autoimmune and inflammatory diseases.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Therapeutics
Wellness
Health Care

Date founded

2016

Funding rounds raised

Total raised

$80M

from 10 investors over 10 rounds

P

Pandion Therapeutics raised $80M on April 1, 2020

Investors: S.R. One Ltd, Mission BioCapital, Polaris Partners, RA Capital Management, L.P., JDRF T1D Fund, OrbiMed Advisors and Versant Ventures

P

Pandion Therapeutics raised $58M on January 17, 2018

Investors: S.R. One Ltd, Versant Ventures and Polaris Partners

FAQ